Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2011-7-7
pubmed:abstractText
Increased expression of FGFR-4 and its ligands have been linked to lethal prostate cancer (PCa). Furthermore, a germ line polymorphism in the FGFR-4 gene, resulting in arginine at codon 388 (Arg³??) instead of glycine (Gly³??), is associated with aggressive disease. The FGFR-4 Arg³?? variant results in increased receptor stability, sustained receptor activation, and increased motility and invasion compared with Gly³??. However, the impact of sustained signaling on cellular signal transduction pathways is unknown.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4355-66
pubmed:meshHeading
pubmed-meshheading:21622724-Alleles, pubmed-meshheading:21622724-Cell Line, Tumor, pubmed-meshheading:21622724-Cluster Analysis, pubmed-meshheading:21622724-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:21622724-Gene Expression Profiling, pubmed-meshheading:21622724-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21622724-Gene Knockdown Techniques, pubmed-meshheading:21622724-Humans, pubmed-meshheading:21622724-Male, pubmed-meshheading:21622724-Neoplasm Invasiveness, pubmed-meshheading:21622724-Neoplasm Metastasis, pubmed-meshheading:21622724-Prostatic Neoplasms, pubmed-meshheading:21622724-Receptor, Fibroblast Growth Factor, Type 4, pubmed-meshheading:21622724-Serum Response Factor, pubmed-meshheading:21622724-Signal Transduction, pubmed-meshheading:21622724-Survival Analysis, pubmed-meshheading:21622724-Transcription Factor AP-1
pubmed:year
2011
pubmed:articleTitle
FGFR-4 Arg³?? enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
pubmed:affiliation
Department of Pathology, Baylor College of Medicine, Houston, Texas, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural